News
SAN FRANCISCO (Reuters) -In what she calls the "wild west" of obesity medicines, Missouri-based Amy Spencer is a pioneer.
Spain is investigating the drugmaker Novo Nordisk over concerns that it may be illegally advertising its blockbuster weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results